Roche Holding Ltd. (VTX:ROG) has been assigned a CHF 231 target price by Baader Bank in a report released on Thursday, October 19th. The brokerage currently has a “neutral” rating on the healthcare company’s stock.
Several other equities research analysts have also recently weighed in on ROG. UBS AG set a CHF 260 price target on shares of Roche Holding and gave the company a “neutral” rating in a research report on Thursday, July 6th. Berenberg Bank set a CHF 273 price target on shares of Roche Holding and gave the company a “buy” rating in a research report on Tuesday, August 15th. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on shares of Roche Holding and gave the company a “buy” rating in a research report on Tuesday, August 8th. J P Morgan Chase & Co reissued a “buy” rating on shares of Roche Holding in a research report on Monday, October 2nd. Finally, Deutsche Bank AG set a CHF 260 price target on shares of Roche Holding and gave the company a “neutral” rating in a research report on Friday, July 28th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of CHF 263.
Shares of Roche Holding (ROG) opened at 230.10 on Thursday. The company has a market cap of CHK 196.34 billion and a PE ratio of 20.43. Roche Holding has a 12 month low of CHK 218.30 and a 12 month high of CHK 273.00. The company has a 50-day moving average of CHK 243.34 and a 200 day moving average of CHK 249.92.
TRADEMARK VIOLATION WARNING: This story was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2017/10/28/baader-bank-analysts-give-roche-holding-ltd-rog-a-chf-231-price-target.html.
Roche Holding Company Profile
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.